We recognise the trust our investors place in us and it's not a responsibility we take lightly.

Fisher & Paykel Healthcare
FY 2023 Half Year Results Announcement

Tuesday, 29 November at 10.00am NZDT (8.00am AEDT; 4.00pm USEST, Monday, 28 November)

 
FPH 2023 Annual Report


 
Interim Report 2023

Interim Report for Fisher & Paykel Healthcare for the 2023 financial year.


View report

Latest Investor News

2022/2023 Key Dates

For more information visit our events page

30 September 2022
Financial Half Year End

29 November 2022
Half Year Results Announcement

21 December 2022
Interim Dividend

31 March 2023
2023 Financial Year End

May 2023
Full Year Results Announcement

July 2023
Full Year Dividend

August 2023
Annual Shareholder Meeting

Share Price

FPH

/

Daily volume

Annual average daily
volume

52 week range

-

Compare with:

Chart Last Updated:
FPH 2022 Investor Fact Sheet


Investor Fact Sheet

A short overview of Fisher & Paykel Healthcare's history, financial performance, business areas and management team.


View the investor fact sheet

Investor Information

Shareholders should address questions relating to dividends, certificates or changes of address to Fisher & Paykel Healthcare's share registrar, Link Market Services Limited.

 

New Zealand

LINK Market Services Limited
Level 7, Zurich House
21 Queen Street
Auckland 1010
P O Box 91976
Auckland 1142
Investor enquiries: +64 9 375 5998
Fax: +64 9 375 5990
enquiries@linkmarketservices.co.nz

 

Australia

LINK Market Services Limited
Level 12, 680 George Street
Sydney, NSW 2000
Locked Bag A14
Sydney South
NSW 1235
Investor enquiries: +61 2 8280 7111
Fax: +61 2 9287 0303
registrars@linkmarketservices.com.au

For all other investor inquiries contact 

Hayden Brown
Investor Relations Manager

hayden.brown@fphcare.co.nz

Phone: +64 9 574 0116 extn 7323

Fisher & Paykel Healthcare
15 Maurice Paykel Place
East Tamaki, Auckland 2013
PO Box 14 348
Panmure, Auckland 1741
New Zealand


 

 

Fisher & Paykel Healthcare is listed on the NZX Main Board and Australian Securities Exchange and is governed by the rules of those exchanges. Fisher & Paykel Healthcare does not sponsor, sanction, support or encourage trading in Fisher & Paykel Healthcare shares through third and fourth markets, such as ADR programmes and over the counter trading. Fisher & Paykel Healthcare disclaims any liability whatsoever arising out of any trading through third and fourth markets, including unsponsored ADR programmes and over the counter trading.
 

Subscribe to Investor Alerts

Sign up to receive email notifications of the latest investor news from Fisher & Paykel Healthcare.